Skip to main content
Guidance

Influenza vaccines marketed in the UK

Influenza vaccines marketed in the UK for 2026 to 2027, including ovalbumin content.

Updates to this page

From:
UK Health Security Agency
Published:
1 April 2022
Last updated:
21 July 2026
Show all updates

  1. Updated 'All influenza vaccines marketed in the UK for the 2026 to 2027 season' text and print versions.

  2. Updated 'All influenza vaccines marketed in the UK for the 2026 to 2027 season' text and print versions.

  3. Updated 'All influenza vaccines marketed in the UK for the 2025 to 2026 season' text and print versions.

  4. Updated 'All influenza vaccines marketed in the UK for the 2025 to 2026 season' text and print versions.

  5. Added 'All influenza vaccines marketed in the UK for the 2025 to 2026 season' text and print versions.

  6. Updated Viatris product field in tables (text and print).

  7. Updated tables (text and print).

  8. Updated 'All influenza vaccines marketed in the UK for the 2024 to 2025 season'.

  9. Updated for the 2024 to 2025 season.

  10. Updated tables (text and print).

  11. Updated table.

  12. First published.

Documents

All influenza vaccines marketed in the UK for the 2026 to 2027 season (text version)

HTML

All influenza vaccines marketed in the UK for the 2026 to 2027 season (print version)

PDF, 220 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This table lists all of the vaccines that are marketed in the UK for the 2026 to 2027 flu vaccination season, including ovalbumin content.

For information on the use of influenza vaccines in egg allergic individuals, see the green book influenza chapter 19.

Sign up for emails or print this page

Related content